Fig. 4: Treatment-free remission (TFR) after second tyrosine kinase inhibitor (TKI) discontinuation by first TFR duration. | Leukemia

Fig. 4: Treatment-free remission (TFR) after second tyrosine kinase inhibitor (TKI) discontinuation by first TFR duration.

From: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib – interim results from the DAstop2 trial

Fig. 4

Patients with a second discontinuation divided by whether the time to molecular relapse after the first discontinuation attempt was more or less than 6 months. The log rank test was used when comparing groups.

Back to article page